Completed
Humanized Anti-GD2 Antibody Hu3F8 and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma
NCT02650648
- Conditions
- High-risk, Neoplasms, Neoplasms by Histologic Type, +8 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States